These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New high-technology products for the treatment of haemophilia. Pipe SW; Saint-Remy JM; Walsh CE Haemophilia; 2004 Oct; 10 Suppl 4():55-63. PubMed ID: 15479373 [TBL] [Abstract][Full Text] [Related]
3. The molecular pathology of haemophilia. Larner AJ Q J Med; 1987 Jun; 63(242):473-91. PubMed ID: 2889239 [TBL] [Abstract][Full Text] [Related]
4. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Snyder RO; Miao CH; Patijn GA; Spratt SK; Danos O; Nagy D; Gown AM; Winther B; Meuse L; Cohen LK; Thompson AR; Kay MA Nat Genet; 1997 Jul; 16(3):270-6. PubMed ID: 9207793 [TBL] [Abstract][Full Text] [Related]
5. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Girolami A; Scandellari R; Scapin M; Vettore S Vitam Horm; 2008; 78():281-374. PubMed ID: 18374200 [TBL] [Abstract][Full Text] [Related]
8. [New approaches to haemophilia treatment--recombinant and transgenic concentrates, gene therapy and engineered coagulation factors]. Habart D Cas Lek Cesk; 2006; 145(2):104-11. PubMed ID: 16521398 [TBL] [Abstract][Full Text] [Related]
9. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
11. [Obtaining plasma derivatives for coagulation versus new non-human sources for obtaining factors]. Rutllant ML Sangre (Barc); 1984; 29(4-C):680-91. PubMed ID: 6096972 [No Abstract] [Full Text] [Related]
12. Cryobiology in human assisted reproductive technology. Would Hippocrates approve? Bredkjaer HE; Grudzinskas JG Early Pregnancy (Cherry Hill); 2001 Jul; 5(3):211-3. PubMed ID: 11753534 [TBL] [Abstract][Full Text] [Related]
13. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia. High KA Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929 [TBL] [Abstract][Full Text] [Related]
14. Beware the Medical-Industrial Complex. Stevens CW; Glatstein E Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005 [TBL] [Abstract][Full Text] [Related]
15. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B. Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068 [TBL] [Abstract][Full Text] [Related]
17. Laboratory support in the diagnosis of coagulation disorders. Giddings JC; Peake IR Clin Haematol; 1985 Jun; 14(2):571-95. PubMed ID: 3899445 [TBL] [Abstract][Full Text] [Related]
18. "Just Another Statistic". Machtay M; Glatstein E Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105 [TBL] [Abstract][Full Text] [Related]
19. Future materials for foot surgery. Latour RA Clin Podiatr Med Surg; 1995 Jul; 12(3):519-44. PubMed ID: 7553538 [TBL] [Abstract][Full Text] [Related]
20. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders]. Fischer M Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]